Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect.
D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects*; D001923:Brain Chemistry; D003863:Depression / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D004357:Drug Synergism; D004597:Electroshock; D006801:Humans; D007099:Imipramine / Q000494:pharmacology; D007737:Kynurenine / Q000096:biosynthesis; D008099:Liver / Q000187:drug effects; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D012701:Serotonin / Q000096:biosynthesis / Q000378:metabolism / Q000494:pharmacology* / Q000502:physiology / Q000627:therapeutic use; D012702:Serotonin Antagonists; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014364:Tryptophan / Q000627:therapeutic use; D014366:Tryptophan Oxygenase / Q000037:antagonists & inhibitors
D000305:Adrenal Cortex Hormones; D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D012702:Serotonin Antagonists; D014149:Tranquilizing Agents; D012701:Serotonin; D007737:Kynurenine; D014364:Tryptophan; D014366:Tryptophan Oxygenase; D007099:Imipramine